Clinical Trial

Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of the proposed study is to conduct the first ever prospective, dose-exploration trial to test the feasibility of early administration of gabapentin as an intervention for neurorecovery. This research project falls under the Intervention Development stage of research as the primary goal is to assess the feasibility of conducting a well-designed intervention efficacy study in the future.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-29; most recent amendment 2025-11-24.
Trial Details
NCT Number NCT05302999
Lead Sponsor MetroHealth Medical Center
Collaborators: National Institute on Disability, Independent Living, and Rehabilitation Research
Conditions Spinal Cord Injuries
Enrollment 42 participants
Start Date 2022-03-14
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-02